Clinical trials
Phase 2 Diabetes Mellitus, Type 2 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 10 |
| Eli Lilly and Company | 9 |
| AstraZeneca | 5 |
| Amgen | 3 |
| Boehringer Ingelheim | 3 |
| Hoffmann-La Roche | 3 |
| Ionis Pharmaceuticals, Inc. | 3 |
| Sanofi | 3 |
| GlaxoSmithKline | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 63 |
| Diabetes Mellitus | 8 |
| Obesity | 5 |
| Diabetic Nephropathies | 4 |
| Renal Insufficiency, Chronic | 4 |
| Albuminuria | 3 |
| Diabetes Mellitus, Type 1 | 2 |
| Gastroparesis | 2 |
| Heart Failure | 2 |
| Hypertension | 2 |
Trials
Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.